Short Communication
Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients
Article first published online: 22 APR 2004
DOI: 10.1002/pmic.200300715
Copyright © 2004 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Issue

PROTEOMICS
Special Issue: Proceedings of the AEPS Meeting, Melbourne, Australia 27-28 September 2003
Volume 4, Issue 7, pages 2117–2124, July 2004
Additional Information
How to Cite
Dumont, D., Noben, J.-P., Raus, J., Stinissen, P. and Robben, J. (2004), Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. PROTEOMICS, 4: 2117–2124. doi: 10.1002/pmic.200300715
Publication History
- Issue published online: 22 JUN 2004
- Article first published online: 22 APR 2004
- Manuscript Received: 6 OCT 2003
- Abstract
- References
- Cited By
Keywords:
- Cerebrospinal fluid;
- Liquid chromatography;
- Mass spectrometry;
- Multiple sclerosis;
- Two-dimensional gel electrophoresis
Abstract
Multiple sclerosis is an autoimmune inflammatory demyelinating disease of the central nervous system. Disease mechanisms in multiple sclerosis at the molecular level remain poorly understood and no reliable proteinaceous disease markers are available yet. The goal of the present study is the construction of a protein database of two-dimensional gel electrophoresis (2-DE) separated cerebrospinal fluid (CSF) proteins from multiple sclerosis patients. By means of liquid chromatography tandem mass spectrometry 65 different proteins were identified from 300 spots. Eighteen of these proteins have not been reported previously on 2-DE gels of CSF. Here we report on the identification of these proteins and discuss their potential relation to multiple sclerosis.

1615-9861/asset/olbannerleft.gif?v=1&s=5e7e0f1cdb0951c5b1ba024be31918c1f138c065)